Bachem Holding AG
BANB
Rankning i aktier
#2516
Bachem Holding AG serves pharmaceutical and biotechnology companies globally,... Bachem Holding AG serves pharmaceutical and biotechnology companies globally, providing products crucial for research, clinical development, and commercial use. The company's primary focus is on the design, manufacturing, and regulatory support for peptide active pharmaceutical ingredients (APIs), specifically targeting novel peptide and oligonucleotide chemical entities (NCEs). Additionally, Bachem offers commercially available NCEs and generic compounds. Its comprehensive service portfolio includes project management, quality assurance and regulatory guidance, analytical testing, production adhering to Good Manufacturing Practices (GMP), manufacturing for research purposes, and expertise in supply chain and vertical integration. Established in 1971, Bachem Holding AG is headquartered in Bubendorf, Switzerland, and functions as a subsidiary of Ingro Finanz AG.
Aktiekurs
$100.60
Marknadsvärde
$7.54B
Förändring (1 dag)
-1.49%
Förändring (1 år)
49.53%
Land
CH
Handel Bachem Holding AG (BANB)
Kategori
Healthcare
Vinst för Bachem Holding AG (BANB)
Vinst i 2026 TTM: 0
Enligt de senaste finansiella rapporterna från Bachem Holding AG är företagets nuvarande vinst 0. År 2026 hade företaget en vinst på 0, lika med vinsten år 2026 som var 0. Vinsten som visas på denna sida är vinsten före räntor och skatt, även kallad EBIT.
Vinshistorik för Bachem Holding AG från 2002 till 2026
Vinst vid slutet av varje år
| År | Vinst | Ändra |
|---|---|---|
| 2025 | $197.08M | 31.67% |
| 2024 | $149.68M | 1.35% |
| 2023 | $147.69M | 21.84% |
| 2022 | $121.22M | -15.88% |
| 2021 | $144.11M | 42.32% |
| 2020 | $101.26M | 62.26% |
| 2019 | $62.40M | 12.36% |
| 2018 | $55.54M | 11.92% |
| 2017 | $49.63M | 10.07% |
| 2016 | $45.08M | 20.90% |
| 2015 | $37.29M | 1.92% |
| 2014 | $36.59M | 12.98% |
| 2013 | $32.38M | 52.96% |
| 2012 | $21.17M | 62.51% |
| 2011 | $13.03M | -61.93% |
| 2010 | $34.22M | -23.54% |
| 2009 | $44.76M | -29.32% |
| 2008 | $63.33M | -12.95% |
| 2007 | $72.75M | 49.11% |
| 2006 | $48.79M | 30.20% |
| 2005 | $37.47M | 1.17% |
| 2004 | $37.04M | -5.60% |
| 2003 | $39.24M | 21.47% |
| 2002 | $32.30M | 0.00% |
Vinst för liknande företag eller konkurrenter
| Företag | Vinst | Skillnad i vinst | Land |
|---|---|---|---|
| $5.27B | - |
US
|
|
| $-3.09B | - |
US
|
|
| $-4.02B | - |
AU
|
|
| $1.95B | - |
NL
|
|
| - | - |
CH
|
